{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:16:56Z","timestamp":1791433016399,"version":"4.3.3"},"reference-count":36,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH grants P50 CA107399"],"award-info":[{"award-number":["NIH grants P50 CA107399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA033572"],"award-info":[{"award-number":["P30 CA033572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007118","name":"the Skirball Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007118","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Tim Nesvig Lymphoma Research Foundation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40425-017-0227-4","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T21:14:36Z","timestamp":1488402876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy"],"prefix":"10.1136","volume":"5","author":[{"given":"Ryan","family":"Urak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChingLam W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua E.","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"227_CR1","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","volume":"3","author":"M Kalos","year":"2011","unstructured":"Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med. 2011;3:95ra73.","journal-title":"Sci Transl Med"},{"key":"227_CR2","doi-asserted-by":"crossref","first-page":"177ra138","DOI":"10.1126\/scitranslmed.3005930","volume":"5","author":"RJ Brentjens","year":"2013","unstructured":"Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M, et al. CD19-targeted t cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med. 2013;5:177ra138.","journal-title":"Sci Transl Med"},{"key":"227_CR3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.1882","volume":"14","author":"MA Pule","year":"2008","unstructured":"Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV, Dotti G, Huls MH, Liu E, Gee AP, Mei Z, et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med. 2008;14:1264\u201370.","journal-title":"Nat Med"},{"key":"227_CR4","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","volume":"17","author":"SA Rosenberg","year":"2011","unstructured":"Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. 2011;17:4550\u20137.","journal-title":"Clin Cancer Res"},{"key":"227_CR5","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1200\/JCO.2008.16.5449","volume":"26","author":"ME Dudley","year":"2008","unstructured":"Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008;26:5233\u20139.","journal-title":"J Clin Oncol"},{"key":"227_CR6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jgm.2637","volume":"14","author":"BJ Uttenthal","year":"2012","unstructured":"Uttenthal BJ, Chua I, Morris EC, Stauss HJ. Challenges in T cell receptor gene therapy. J Gene Med. 2012;14:386\u201399.","journal-title":"J Gene Med"},{"key":"227_CR7","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","volume":"115","author":"L Gattinoni","year":"2005","unstructured":"Gattinoni L, Klebanoff CA, Palmer DC, Wrzesinski C, Kerstann K, Yu Z, Finkelstein SE, Theoret MR, Rosenberg SA, Restifo NP. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest. 2005;115:1616\u201326.","journal-title":"J Clin Invest"},{"key":"227_CR8","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2010-10-310599","volume":"117","author":"X Wang","year":"2011","unstructured":"Wang X, Berger C, Wong CW, Forman SJ, Riddell SR, Jensen MC. Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice. Blood. 2011;117:1888\u201398.","journal-title":"Blood"},{"key":"227_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","volume":"118","author":"C Berger","year":"2008","unstructured":"Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8 T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest. 2008;118:294\u2013305.","journal-title":"J Clin Invest"},{"key":"227_CR10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290\u20137.","journal-title":"Nat Med"},{"key":"227_CR11","first-page":"20","volume":"4","author":"EH Kim","year":"2013","unstructured":"Kim EH, Suresh M. Role of PI3K\/Akt signaling in memory CD8 T cell differentiation. Front Immunol. 2013;4:20.","journal-title":"Front Immunol"},{"key":"227_CR12","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.4049\/jimmunol.169.7.3637","volume":"169","author":"JK Yoo","year":"2002","unstructured":"Yoo JK, Cho JH, Lee SW, Sung YC. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase\/Akt signaling pathway. J Immunol. 2002;169:3637\u201343.","journal-title":"J Immunol"},{"key":"227_CR13","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.4049\/jimmunol.1103568","volume":"188","author":"EH Kim","year":"2012","unstructured":"Kim EH, Sullivan JA, Plisch EH, Tejera MM, Jatzek A, Choi KY, Suresh M. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J Immunol. 2012;188:4305\u201314.","journal-title":"J Immunol"},{"key":"227_CR14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","volume":"15","author":"L Gattinoni","year":"2009","unstructured":"Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, Wrzesinski C, Boni A, Cassard L, Garvin LM, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med. 2009;15:808\u201313.","journal-title":"Nat Med"},{"key":"227_CR15","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2014-05-578583","volume":"124","author":"AB Waart van der","year":"2014","unstructured":"van der Waart AB, van de Weem NM, Maas F, Kramer CS, Kester MG, Falkenburg JH, Schaap N, Jansen JH, van der Voort R, Gattinoni L, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490\u2013500.","journal-title":"Blood"},{"key":"227_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","volume":"75","author":"JG Crompton","year":"2015","unstructured":"Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil RL, Tran E, Hanada K, Yu Z, Palmer DC, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2015;75:296\u2013305.","journal-title":"Cancer Res"},{"key":"227_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/BF02621085","volume":"22","author":"F Pelloquin","year":"1986","unstructured":"Pelloquin F, Lamelin JP, Lenoir GM. Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A. In Vitro Cell Dev Biol. 1986;22:689\u201394.","journal-title":"In Vitro Cell Dev Biol"},{"key":"227_CR18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CJI.0b013e318270dec7","volume":"35","author":"X Wang","year":"2012","unstructured":"Wang X, Naranjo A, Brown CE, Bautista C, Wong CW, Chang WC, Aguilar B, Ostberg JR, Riddell SR, Forman SJ, Jensen MC. Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale. J Immunother. 2012;35:689\u2013701.","journal-title":"J Immunother"},{"key":"227_CR19","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","volume":"66","author":"CM Kowolik","year":"2006","unstructured":"Kowolik CM, Topp MS, Gonzalez S, Pfeiffer T, Olivares S, Gonzalez N, Smith DD, Forman SJ, Jensen MC, Cooper LJ. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res. 2006;66:10995\u20131004.","journal-title":"Cancer Res"},{"key":"227_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mt.2014.208","volume":"23","author":"M Jonnalagadda","year":"2015","unstructured":"Jonnalagadda M, Mardiros A, Urak R, Wang X, Hoffman LJ, Bernanke A, Chang WC, Bretzlaff W, Starr R, Priceman S, et al. Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol Ther. 2015;23:757\u201368.","journal-title":"Mol Ther"},{"key":"227_CR21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","volume":"118","author":"X Wang","year":"2011","unstructured":"Wang X, Chang WC, Wong CW, Colcher D, Sherman M, Ostberg JR, Forman SJ, Riddell SR, Jensen MC. A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells. Blood. 2011;118:1255\u201363.","journal-title":"Blood"},{"key":"227_CR22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/intimm\/dxg087","volume":"15","author":"K Kimachi","year":"2003","unstructured":"Kimachi K, Sugie K, Grey HM. Effector T cells have a lower ligand affinity threshold for activation than naive T cells. Int Immunol. 2003;15:885\u201392.","journal-title":"Int Immunol"},{"key":"227_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2567.2002.01447.x","volume":"106","author":"M Berard","year":"2002","unstructured":"Berard M, Tough DF. Qualitative differences between naive and memory T cells. Immunology. 2002;106:127\u201338.","journal-title":"Immunology"},{"key":"227_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-8-104","volume":"8","author":"Y Li","year":"2010","unstructured":"Li Y, Kurlander RJ. Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation. J Transl Med. 2010;8:104.","journal-title":"J Transl Med"},{"key":"227_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2011.01.012","volume":"34","author":"AN Macintyre","year":"2011","unstructured":"Macintyre AN, Finlay D, Preston G, Sinclair LV, Waugh CM, Tamas P, Feijoo C, Okkenhaug K, Cantrell DA. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity. 2011;34:224\u201336.","journal-title":"Immunity"},{"key":"227_CR26","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1158\/1078-0432.CCR-14-2920","volume":"21","author":"X Wang","year":"2015","unstructured":"Wang X, Wong CW, Urak R, Mardiros A, Budde LE, Chang WC, Thomas SH, Brown CE, Rosa C, Diamond DJ, et al. CMVpp65 vaccine enhances the antitumor efficacy of adoptively transferred CD19-redirected CMV-specific T cells. Clin Cancer Res. 2015;21:2993\u20133002.","journal-title":"Clin Cancer Res"},{"key":"227_CR27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2012-05-431718","volume":"121","author":"N Cieri","year":"2013","unstructured":"Cieri N, Camisa B, Cocchiarella F, Forcato M, Oliveira G, Provasi E, Bondanza A, Bordignon C, Peccatori J, Ciceri F, et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood. 2013;121:573\u201384.","journal-title":"Blood"},{"key":"227_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","volume":"249","author":"AT Waickman","year":"2012","unstructured":"Waickman AT, Powell JD. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev. 2012;249:43\u201358.","journal-title":"Immunol Rev"},{"key":"227_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.tp.0000194860.21533.b9","volume":"81","author":"N Nikolaeva","year":"2006","unstructured":"Nikolaeva N, Bemelman FJ, Yong SL, van Lier RA, ten Berge IJ. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells. Transplantation. 2006;81:445\u201354.","journal-title":"Transplantation"},{"key":"227_CR30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2005-07-3032","volume":"107","author":"JJ Coenen","year":"2006","unstructured":"Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4\u2009+\u2009CD25+ regulatory T cells. Blood. 2006;107:1018\u201323.","journal-title":"Blood"},{"key":"227_CR31","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.pbio.1000017","volume":"7","author":"V Calleja","year":"2009","unstructured":"Calleja V, Laguerre M, Parker PJ, Larijani B. Role of a novel PH-kinase domain interface in PKB\/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 2009;7:e17.","journal-title":"PLoS Biol"},{"key":"227_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00262-012-1378-2","volume":"62","author":"S Yang","year":"2013","unstructured":"Yang S, Ji Y, Gattinoni L, Zhang L, Yu Z, Restifo NP, Rosenberg SA, Morgan RA. Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol Immunother. 2013;62:727\u201336.","journal-title":"Cancer Immunol Immunother"},{"key":"227_CR33","doi-asserted-by":"crossref","first-page":"e1072671","DOI":"10.1080\/2162402X.2015.1072671","volume":"5","author":"X Wang","year":"2016","unstructured":"Wang X, Wong CW, Urak R, Taus E, Aguilar B, Chang WC, Mardiros A, Budde LE, Brown CE, Berger C, et al. Comparison of naive and central memory derived CD8 effector cell engraftment fitness and function following adoptive transfer. Oncoimmunology. 2016;5:e1072671.","journal-title":"Oncoimmunology"},{"key":"227_CR34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood-2010-05-286286","volume":"117","author":"CS Hinrichs","year":"2011","unstructured":"Hinrichs CS, Borman ZA, Gattinoni L, Yu Z, Burns WR, Huang J, Klebanoff CA, Johnson LA, Kerkar SP, Yang S, et al. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy. Blood. 2011;117:808\u201314.","journal-title":"Blood"},{"key":"227_CR35","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","volume":"126","author":"CJ Turtle","year":"2016","unstructured":"Turtle CJ, Hanafi LA, Berger C, Gooley TA, Cherian S, Hudecek M, Sommermeyer D, Melville K, Pender B, Budiarto TM, et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Invest. 2016;126:2123\u201338.","journal-title":"J Clin Invest"},{"key":"227_CR36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/BST20120359","volume":"41","author":"DK Finlay","year":"2013","unstructured":"Finlay DK. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB. Biochem Soc Trans. 2013;41:681\u20136.","journal-title":"Biochem Soc Trans"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-017-0227-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:42:31Z","timestamp":1601041351000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-017-0227-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1186\/s40425-017-0227-4","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"article-number":"26"}}